Atezolizumab plus stereotactic ablative radiotherapy for medically inoperable patients with early-stage non-small cell lung cancer: a multi-institutional phase I trial

Arta M. Monjazeb, Karen Kelly, Guillaume Luxardi et al.|Nature Communications|2023

Cited by 21